In the BioHarmony Drug Report Database

"Preview" Icon

Tiotropium bromide

Spiriva, Spiriva Respimat (tiotropium bromide) is a small molecule pharmaceutical. Tiotropium bromide was first approved as Spiriva on 2004-01-30. It is used to treat chronic bronchitis and pulmonary emphysema in the USA. The pharmaceutical is active against muscarinic acetylcholine receptor M3. In addition, it is known to target muscarinic acetylcholine receptor M2, muscarinic acetylcholine receptor M1, muscarinic acetylcholine receptor M5, and muscarinic acetylcholine receptor M4. Spiriva handihaler’s patents are valid until 2030-10-16 (FDA).

 

Trade Name

 

Spiriva, Spiriva Respimat
 

Common Name

 

tiotropium bromide
 

ChEMBL ID

 

CHEMBL3545181
 

Indication

 

chronic bronchitis, pulmonary emphysema
 

Drug Class

 

Quaternary ammonium derivatives; atropine derivatives

Image (chem structure or protein)

Tiotropium bromide structure rendering